spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Fujirebio Diagnostics 

 HSMN NewsFeed - 5 Sep 2017
Morphotek(R), Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab(R)
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 6 Sep 2011
FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass
Diagnostics Oncology FDA
 HSMN NewsFeed - 31 May 2011
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 3 Jun 2010
Abbott Receives FDA Clearance for New Ovarian Cancer Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 8 Feb 2010
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Diagnostics Oncology FDA
 HSMN NewsFeed - 14 Jan 2010
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Diagnostics Regulatory Oncology
 HSMN NewsFeed - 4 May 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
Diagnostics Oncology
 HSMN NewsFeed - 11 Feb 2009
Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Diagnostics Oncology
 HSMN NewsFeed - 27 Jan 2009
Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbott s Architect(R) Analyzers
Diagnostics Oncology
 HSMN NewsFeed - 16 Dec 2008
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Diagnostics Oncology Licensing
 HSMN NewsFeed - 26 Mar 2007
CISBIO Announces FDA Approval of MESOMARK(R) Assay Now Availabe to Physicians in the U.S. for Monitoring Patients with Mesothelioma
Diagnostics Oncology FDA
 HSMN NewsFeed - 25 Jan 2007
Fujirebio Diagnostics Receives FDA Approval for the MESOMARK(R) Assay for the Management of Mesothelioma Patients
Diagnostics Oncology FDA
 HSMN NewsFeed - 31 May 2006
Fujirebio Diagnostics Acquires CanAg Diagnostics
Diagnostics Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 11

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 11 additional stories matching:
Fujirebio Diagnostics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.